TechnoStart

Wealthcome has created a technological ecosystem for all players involved in wealth management, private management, and personal finance management. Our objective is straightforward: to make all phases of asset monitoring, analysis, and optimization accessible, simple, enjoyable, and exact.

Nurea develops a decision-making support solution specifically for healthcare professionals, particularly vascular surgeons. The company specializes in medical imaging software that automates image analysis, providing accurate quantitative assessments to aid in the diagnosis of vascular diseases. Its platform facilitates the management of patient groups during both pre- and post-operative monitoring through an automated workflow, which includes comprehensive full-body scan analysis. By offering decision indicators aimed at preventing cardiovascular incidents, Nurea simplifies the decision-making process for surgeons, enhancing patient care in the realm of cardiovascular health. An online inquiry form is available on their website for further information.

VISME rehabilitation service. Medical service providing new opportunities for rehabilitation. They work at the junction of neurobiology and machine learning. They use computer vision technologies to automatize the methods of rehabilitation.

Novaled AG is a technology provider specializing in organic light-emitting diode (OLED) technologies, targeting the organic electronics market. Based in Dresden, Germany, and established in 2003, the company focuses on high-efficiency, long-lifetime OLED structures, leveraging its expertise in synthetic and analytical chemistry. Novaled offers complete solutions that include its proprietary Doping technology and materials, catering to customers in various sectors, including televisions and mobile devices. The company has built strong partnerships with major players in the OLED industry and holds a robust intellectual property portfolio, with over 500 patents granted or pending. Additionally, Novaled maintains branch offices in Asia to support its global operations.

Ascendis Pharma A/S is a biopharmaceutical company based in Hellerup, Denmark, focused on developing prodrug therapies to address unmet medical needs. Leveraging its innovative TransCon technology platform, the company aims to create superior prodrugs across various drug classes, including proteins, peptides, and small molecules. Its pipeline includes TransCon growth hormone, which has completed Phase III clinical trials for treating growth hormone deficiency in children, and TransCon parathyroid hormone, currently in Phase II trials for hypoparathyroidism. Additionally, TransCon CNP is in Phase II development for achondroplasia. Ascendis Pharma also explores preclinical studies in oncology and employs strategic collaborations to enhance its product development, aiming for systemic and localized drug delivery. The company primarily operates in North America, with additional activities in Europe and China.

Novaled AG is a technology provider specializing in organic light-emitting diode (OLED) technologies, targeting the organic electronics market. Based in Dresden, Germany, and established in 2003, the company focuses on high-efficiency, long-lifetime OLED structures, leveraging its expertise in synthetic and analytical chemistry. Novaled offers complete solutions that include its proprietary Doping technology and materials, catering to customers in various sectors, including televisions and mobile devices. The company has built strong partnerships with major players in the OLED industry and holds a robust intellectual property portfolio, with over 500 patents granted or pending. Additionally, Novaled maintains branch offices in Asia to support its global operations.

NXN Software is supplier of Digital Asset and Production Management solutions for the computer graphics and digital entertainment industries.